Cervical cancer therapies: Current challenges and future perspectives CA Burmeister, SF Khan, G Schäfer, N Mbatani, T Adams, J Moodley, ... Tumour Virus Research 13, 200238, 2022 | 141 | 2022 |
The roles and regulation of TBX3 in development and disease SF Khan, V Damerell, R Omar, M Du Toit, M Khan, HM Maranyane, ... Gene 726, 144223, 2020 | 71 | 2020 |
Cervical cancer therapies: current challenges and future perspectives Tumour Virus Res, 13 (2022) CA Burmeister, SF Khan, G Schäfer, N Mbatani, T Adams, J Moodley, ... Article 200238 (10.1016), 2022 | 5 | 2022 |
TBX3 promotes cervical cancer proliferation and migration via HPV E6 and E7 signaling SF Khan, CA Burmeister, DJ Scott, M Sinkala, A Ramburan, HT Wu, ... Molecular Cancer Research 21 (4), 345-358, 2023 | 1 | 2023 |
Strongylopus grayii tadpole blastema extract exerts cytotoxic effects on embryonal rhabdomyosarcoma cells V Harrison, SF Khan, V Damerell, J Bleloch, KN ArulJothi, M Sinkala, ... In Vitro Cellular & Developmental Biology-Animal 58 (8), 679-692, 2022 | 1 | 2022 |
Trinuclear ruthenium (II) polypyridyl complexes: Evaluation as photosensitizers for enhanced cervical cancer treatment A Welsh, R Matshitse, SF Khan, T Nyokong, S Prince, GS Smith Journal of Inorganic Biochemistry 256, 112545, 2024 | | 2024 |
Aminoquinoline-based Re (I) tricarbonyl complexes: Insights into their antiproliferative activity and mechanisms of action PS Zinman, A Welsh, RO Omondi, S Khan, S Prince, E Nordlander, ... European Journal of Medicinal Chemistry 266, 116094, 2024 | | 2024 |
The diaryl-imidazopyridazine anti-plasmodial compound, MMV652103, exhibits anti-breast cancer activity A Neumann-Mufweba, S Kimani, SF Khan, K Chibale, S Prince EXCLI journal 21, 656, 2022 | | 2022 |
Repurposing drugs that target the interaction between HPV and TBX3 to treat cervical cancer SF Khan | | |